SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 53.47+0.3%Nov 28 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Vector1 who wrote (7538)12/18/2002 5:08:29 PM
From: ewolf   of 52153
 
I don't think you're missing anything. Bex market will be an evolving process. The drug has to prove itself with more usage. They're conducting trials to compare efficacy. The manufacturing has yet to be certified. It won't be on the market for at least five months. Still a case of what you believe will happen. I thought it would have dropped to the threes at least on turn down. I'm sure approval for marketing will add a more significant amount than today but it's anyone's guess what the price of the stock will be at that moment in time.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News